Novel PET tracers and their future use in assessment of response to treatment

Open Window project improves patient quality of life

Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in patients with refractory disease

How malignant cells in patients with CLL escape T-cell recognition

Treating metastatic melanoma with vemurafenib

Clinical trials for rare tumour types

Role of family history and genetic testing in diagnosis

First line treatment against metastatic breast cancer

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Effects of lapatinib and trastuzumab on progression free survival

Decision making in surgical breast cancer treatment